Senior Investor Relations Director – AI Biotech

XtalPi Inc.; New York (NY); In loco; USD 150.000 - 210.000; Tempo pieno

Descrizione del lavoro

XtalPi Inc. in the United States is seeking a seasoned Investor Relations professional to strengthen our capital markets presence in New York or Boston. You will engage with U.S.

institutional investors and analysts and help shape the equity story of a fast-growing AI biotech leader listed in Hong Kong. The role requires 8+ years in equity research or in-house IR, strong communication, and an existing network with U.S. investors.

Competenze

• 8+ years of experience in equity research (sell-side or buy-side) covering biotech/pharma/AI, or in-house IR at a publicly listed company.
• Deep understanding of capital markets, valuation, and investor behavior.
• Existing network with U.S. institutional investors and analysts.
• Experience with Hong Kong-listed companies or cross-border capital markets is a plus.
• Excellent communication and presentation skills in English; Mandarin is a plus.

Mansioni

• Develop and execute investor relations strategy for U.S. and global institutional investors.
• Build and maintain relationships with sell-side and buy-side analysts covering biotech, AI, and healthcare.
• Prepare earnings materials, investor presentations, press releases, and other disclosures.
• Monitor market trends, peer performance, and shareholder composition.
• Lead investor meetings, roadshows, and conferences.
• Collaborate with CFO on messaging, guidance, and crisis communication.
• Provide market intelligence and competitive analysis to senior management.

Conoscenze

Investor relations

Equity research

Capital markets

Investor presentations

Communication

English

Mandarin

Descrizione del lavoro

XtalPi Inc. in the United States is seeking a seasoned Investor Relations professional to strengthen our capital markets presence in New York or Boston. You will engage with U.S.

institutional investors and analysts and help shape the equity story of a fast-growing AI biotech leader listed in Hong Kong. The role requires 8+ years in equity research or in-house IR, strong communication, and an existing network with U.S. investors.